Kyowa Hakko News Releases 2007
- October 30, 2007
- Kyowa Hakko Kogyo Co., Ltd.Fiscal 2007 First Half Results
(231KB) - October 29, 2007
- Kyowa Hakko Interim Operating Income up 25.2%(32KB)
- October 22, 2007
- Strategic Alliance Between Kyowa Hakko Group and Kirin Group(569KB)
- October 22, 2007
- Notification with Respect to the Conclusion of the Share Exchange Agreement
Between Kyowa Hakko Kogyo Co., Ltd. and Kirin Pharma Company, Limited(331KB) - October 22, 2007
- Kirin Holdings Company, Limited's Press Release:
“Notification with Respect to Commencement of Tender Offer for Shares of Kyowa Hakko Kogyo Co., Ltd.”(497KB) - October 22, 2007
- Notification with Respect to Approval of Tender Offer For Shares of Kyowa Hakko Kogyo Co., Ltd.(57KB)
- October 22, 2007
- Notification with Respect to the Strategic Alliance Between Kyowa Hakko Group and Kirin Group Centering Around the Integration of Kyowa Hakko Kogyo Co., Ltd. and Kirin Pharma Company, Limited(150KB)
- October 22, 2007
- Strategic Alliance Between Kyowa Hakko Group and Kirin Group
Maximizing Synergy Through an Alliance Centered Around the Pharmaceutical Business(80KB) - July 27, 2007
- Kyowa Hakko licensed to BioWa (wholly owned subsidiary in US),
a novel antibody engineering technology (COMPLEGENT™)
for the efficacy enhancement of therapeutic antibodies - July 27, 2007
- Kyowa Hakko Three-month Net Sales up 10.8%;
Raises profit forecasts(25KB) - April 27, 2007
- Kyowa Hakko Fiscal 2006 Operating Income up 20.2%(73KB)
- April 27, 2007
- Submission of New Drug Application
for Istradefylline(KW-6002),
an investigational anti-Parkinson's disease drug - April 27, 2007
- Kyowa Hakko in-licenses ARQ 197,
an anticancer agent in clinical development,
from the US company ArQule. - March 6, 2007
- Kyowa Hakko Kogyo Co., Ltd. licenses
its in-house developed antibody KW-2871
targeting malignant melanoma to
Life Science Pharmaceuticals in the US.
- You need Adobe® Reader® to view these documents.
Download Adobe® Reader® of Adobe Systems here.
